CN1140274C - Gu'anning ointment for treating hyperosteogeny and its prepn. method - Google Patents
Gu'anning ointment for treating hyperosteogeny and its prepn. method Download PDFInfo
- Publication number
- CN1140274C CN1140274C CNB981105327A CN98110532A CN1140274C CN 1140274 C CN1140274 C CN 1140274C CN B981105327 A CNB981105327 A CN B981105327A CN 98110532 A CN98110532 A CN 98110532A CN 1140274 C CN1140274 C CN 1140274C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- days
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 16
- 239000002674 ointment Substances 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title description 3
- 239000003814 drug Substances 0.000 claims abstract description 45
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 11
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 11
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- 241000218176 Corydalis Species 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000011505 plaster Substances 0.000 claims description 15
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 10
- 235000006226 Areca catechu Nutrition 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 239000009286 sanguis draxonis Substances 0.000 claims description 10
- 244000080767 Areca catechu Species 0.000 claims description 9
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 9
- 238000007670 refining Methods 0.000 claims description 9
- 241000903946 Clematidis Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000002893 slag Substances 0.000 claims description 6
- 235000013599 spices Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 238000003763 carbonization Methods 0.000 claims description 3
- 235000019504 cigarettes Nutrition 0.000 claims description 3
- 239000000571 coke Substances 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 241000411851 herbal medicine Species 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 244000235603 Acacia catechu Species 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 210000000988 bone and bone Anatomy 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 231100000862 numbness Toxicity 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 201000010934 exostosis Diseases 0.000 abstract 2
- 201000010930 hyperostosis Diseases 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 241001043298 Croton draco Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 239000008320 black ointment Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 210000003127 knee Anatomy 0.000 abstract 1
- 210000002414 leg Anatomy 0.000 abstract 1
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 abstract 1
- 210000002435 tendon Anatomy 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 description 4
- 239000006071 cream Substances 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000001354 painful effect Effects 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicinal prescription of an external-use emplastrum, namely Gu'anning ointment for treating hyperosteogeny, and a preparation method thereof, which belongs to the technical field of medicine preparation and the preparation method thereof. The Gu'anning ointment having the functions of expelling wind, dissipating cold, promoting blood circulation to remove blood stasis, promoting qi circulation to relieve pain, and strengthening tendon and bone is prepared into black ointment by Chinese herbal medicinal materials of olibanum, myrrh, corydalis tuber, dragon's blood, manchurian wildginger, borneol and muskone in conventional technology according to a certain proportion. The Chinese medicinal prescription has conspicuous curative effect of treating hyperostosis and the symptoms such as the pain, the numbness and the swelling of the neck, the shoulders, the knees, the waist, the legs, etc. caused by hyperostosis and is convenient in use, carry and store.
Description
The present invention is a kind of Chinese medicine plaster for the treatment of hyperosteogeny disease, and this medicine belongs to the preparation and the preparation method technical field of Chinese medicine.
Hyperosteogeny is a series of degeneration of human body osteoarthrosis and surrounding soft tissue and the result of hypertrophy variation, usually with bony spur, hyperosteogeny, spinal canal stenosis, intervertebral disk hernia, ostealleosis, rheumatism involving the bone is commonly referred to as hyperosteogeny, the people is to after the middle age, osteoarthrosis and surrounding soft tissue thereof begin to degenerate and engender the hypertrophy phenomenon, peripheral vessels is oppressed at outgrowth position again, neural and around causing and the pain of region of interest tissue, numb swelling, joint motion is limited etc., all suffer from this sick people the lighter inconvenience of living, weight person's uneasy in either sitting or lying, sleeping and eating is not peaceful, some even permanent disbility, and treating this at present, sick to remove the massage physiotheraping effect be not very desirable, therefore, develops a kind of easy to use, curative effect is certain, cheap external preparation, fit and must go, CN1057965A discloses a kind of prescription and method for making thereof of Kezeng cream of external, and Kezeng cream has certain curative effect for hyperosteogeny, but his effect is not clearly, action time is short, easily recurrence, and price comparison is more expensive.
Purpose of the present invention just provides a kind of with low cost, and hyperosteogeny is had medicine of better therapeutical effect and preparation method thereof.Main contents of the present invention: this medicine is that raw material is made with the Chinese herbal medicine, and its constituent percentage by weight is as follows:
Radix Notoginseng 1.5-2% Rhizoma Chuanxiong 1.5-2% Radix Angelicae Dahuricae 1.5-2% Olibanum 1.5-1%
Myrrha 0.5-1% Semen Persicae 0.5-1% Rhizoma Corydalis 0.5-1% Flos Carthami 0.5-1%
Sanguis Draxonis 0.5-1% Borneolum Syntheticum 0.5-1% catechu 0.5-1% Herba Asari 0.5-1%
Cortex Cinnamomi 0.5-1% Rhizoma Et Radix Notopterygii 0.5-1% Radix Saposhnikoviae 0.5-1% Herba Schizonepetae 0.5-1%
Radix Clematidis 0.5-1% Fructus Psoraleae 0.5-1% Rhizoma Drynariae 1-1.5%
Radix Achyranthis Bidentatae 1-1.5% Radix Angelicae Sinensis 1-1.5% Radix Astragali 1-1.5%
Artificial Moschus 0.1-0.5% Oleum Sesami 50-60% Plumbum preparatium 20-30%.
Preparation method of the present invention comprises the steps:
1, soaks: medicine is weighed accurately by recipe quantity, except that Borneolum Syntheticum, artificial Moschus, get Radix Notoginseng, Olibanum, Myrrha, Sanguis Draxonis, catechu and be ground into fine powder, getting Oleum Sesami soaks medicines such as Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Semen Persicae, Rhizoma Corydalis, Flos Carthami, Radix Astragali, Rhizoma Drynariae, Herba Asari, Cortex Cinnamomi, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Herba Schizonepetae, Radix Clematidis, Fructus Psoraleae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis in Oleum sesami, (steeped spring 5 days, soaked summer 2 days, soaked hot day 7 days, soaked winter 10 days).
2. the fried oil of getting it filled
It is withered and yellow that the medicine that soaked oil is heated to spice with slow fire earlier, and temperature is no more than 220 ℃, and is fried to the outside dark brown of spice, inner coke yellow, but not carbonization, blackening be advisable, from fire cold slightly remove slag, filter promptly get medicine oil.
3. oil refining
The heating of fluid after removing slag is tempered, and treats that refining can descend pellet when dripping into pearl.
4. pilling and pasting
At this moment otherwise stop stirring the good oil of refining is added the Plumbum preparatium,, in case the heavy poly-the bottom of a pan of red powder emits to the greatest extent to white cigarette, medicine oil is taken out during for pitchy by brown stain and splashes on a small quantity in the cold water, takes out after the several seconds, and the tack-free denseness of ointment is suitable.
5. releasing fire-toxin
After plaster was boiled into, impouring was got ready in the cold water and is constantly stirred, and should change cold water in addition when the water heating, and the back of condensing is taken out and pinched pressure repeatedly, and makes agglomerate, is dipped in the cold water, changes water every day one time, soaks (15 days winters, 5 days summers) 7.
6. mix the fines medicine
Get the plaster agglomerate and put in the container, in water-bath, dissolve, make temperature in the time of 60～70 ℃, mix into fines medicines such as Radix Notoginseng, Olibanum, Myrrha, Sanguis Draxonis, catechu, Borneolum Syntheticum, stir evenly.
7. the stand is coated with
Take by weighing the plaster of constant weight, spread out in paper or cloth etc. and mount on the backing material,, the artificial Moschus is spread on the plaster surface can collects standby.
The present invention is that raw material is made with the Chinese herbal medicine, we's Radix Angelicae Dahuricae at first for this reason, Herba Asari, Radix Saposhnikoviae, Herba Schizonepetae, Radix Clematidis, Cortex Cinnamomis etc. win wet with expelling wind and cold, again with Rhizoma Chuanxiong, Olibanum, Myrrha, Semen Persicae, Flos Carthami, Radix Achyranthis Bidentatae, Radix Notoginseng, the product blood circulation promoting and blood stasis dispelling of Sanguis Draxonis, detumescence relieves the pain, qi being the governor of blood, the capable then blood of gas is capable, eliminate as early as possible in order to make local pain caused by ecchymoma, join Rhizoma Corydalis in the event side again, Borneolum Syntheticum, the promoting the circulation of QI to relieve pain of having one's ideas straightened out such as Herba Asari, numbness for a long time must be empty, must nourishing liver and kidney, benefiting QI and nourishing blood, so just again with Rhizoma Drynariae, Fructus Psoraleae, Radix Angelicae Sinensis, nourishing the liver and kidney such as the Radix Astragali, strong muscles and bones, benefiting QI and nourishing blood, catechu is antipruritic with its convergence, and its counteracting toxic substances is mainly used in the Plumbum preparatium in the side, removing dampness is antipruritic, is the excipient of plaster simultaneously.
The medicine of full side is auxilliary mutually to be usefulness, giving consideration to both the incidental and fundamental, and eliminating evil is main, and does not hinder healthy energy, setting upright is to help, and does not stay heresy, and it has expelling wind and cold, blood circulation promoting and blood stasis dispelling, circulation of qi promoting relieve the pain, the effect of bone and muscle strengthening, and reaching the bones and muscles pain and the rheumatic Bi syndrome that cause thus for hyperosteogeny has better curative effect.This medicine is through Hospital Affiliated to Shandong Medical College's clinical observation, the preclinical pharmacology experiment confirm, this medicine has good antiinflammation to acute exudative inflammation, chronic hyperplastic inflammation also had remarkable antagonism, and the painful effect in significant non-specific town is arranged, test by microcirculation improvement, the result as can be seen, this medicine has good antagonism pituitrin and causes the microcirculation disturbance effect, capacity of returns slip in the time of can obviously reducing microcirculation disturbance, this effect of this medicine is one of mechanism of the painful effect in its antiinflammatory town, also from certain angle illustrated compound Chinese medicinal preparation the effect of unique characteristics.The total effective rate that this group is treated two courses of treatment reaches 100%, and curative effect is extremely remarkable, and to cervical spondylosis, hyperosteogeny, three kinds of various disease of intervertebral disk hernia all obtain good therapeutic effect.The effective percentage for the treatment of two courses of treatment illustrates with administration time to prolong that than significantly improving a course of treatment curative effect of this medicine also strengthens, after finishing for second course of treatment, patient's sings and symptoms be improved significantly, all symptoms have 49.7% to disappear, 42.7% alleviates, 7.6% no change is only arranged, illustrate that this medicine has remarkable blood circulation promoting and blood stasis dispelling, bone and muscle strengthening, expelling cold and dampness, the analgesic effect of regulating the flow of vital energy, it is short that we observe the course of disease, and the patient treatment that symptom is lighter is effective.
Toxicological study is found before clinical, this medicine can not produce acute toxic reaction because of contact absorbs to the animal of complete and imperfect skin, skin is had no stimulation, only minimum several animals there is the mild skin anaphylaxis, very fast alleviation after the drug withdrawal, do not have other untoward reaction, illustrate that this clinical drug application safety is reliable.
The present invention has that raw material is extensive, and cost is low, craft science, and constant product quality, effect is lasting, and is easy to use, good effect.This medicine can be used as the at first medicine of treatment hyperosteogeny disease.
Embodiment: manufacture method:
1, soak: medicine is weighed accurately by recipe quantity, except that Borneolum Syntheticum 200g artificial Moschus 100g, get Radix Notoginseng 500g, Olibanum 300g, Myrrha 300g, Sanguis Draxonis 300g, catechu 200g, be ground into fine powder, with Rhizoma Chuanxiong 500g, Radix Angelicae Dahuricae 500g, Semen Persicae 300g, Rhizoma Corydalis 300g, Flos Carthami 300g, Radix Astragali 400g, Rhizoma Drynariae 400g, Herba Asari 200g, Cortex Cinnamomi 300g, Rhizoma Et Radix Notopterygii 300g, Radix Saposhnikoviae 300g, Herba Schizonepetae 300g, Radix Clematidis 300g, Fructus Psoraleae 400g, Radix Achyranthis Bidentatae 400g, Radix Angelicae Sinensis 400g, soak in Oleum Sesami 18000g Deng medicine, (steeped spring 5 days, soaked summer 2 days, soaked autumn 7 days, soaked winter 10 days).
2, the fried oil of getting it filled
It is withered and yellow that the medicine that soaked oil is heated to spice with slow fire earlier, and temperature is no more than 220 ℃, and is fried to the outside dark brown of spice, inner coke yellow, but not carbonization, blackening be advisable, from fire cold slightly remove slag, filter promptly get medicine oil.
3. oil refining
The heating of fluid after removing slag is tempered, and treats that refining can descend pellet when dripping into pearl.
4. pilling and pasting
At this moment otherwise stop stirring the good medicine oil of refining is added Plumbum preparatium 7200g,, in case the heavy poly-the bottom of a pan of red powder, emit to the greatest extent to white cigarette, medicine oil is taken out during for pitchy by brown stain and splashes on a small quantity in the cold water, takes out after the several seconds, if cream is tack-free thick useless suitable.
5. releasing fire-toxin
After plaster was boiled into, impouring was got ready in the cold water and is constantly stirred, and should change cold water in addition when the water heating, and the back of condensing is taken out and pinched pressure repeatedly, and makes agglomerate, is dipped in the cold water, changes water every day one time, soaks (15 days winters, 5 days summers) 7.
6. mix the fines medicine
Get the plaster agglomerate and put in the container, in water-bath, dissolve, make temperature in the time of 60～70 ℃, mix into fines medicines such as Radix Notoginseng 500g, Olibanum 300g, Myrrha 300g, Sanguis Draxonis 300g, catechu 200g, Borneolum Syntheticum 200g, stir evenly.
7. the stand is coated with
Take by weighing the plaster of constant weight, spread out in paper or cloth etc. and mount on the backing material,, artificial Moschus 100g evenly is spread on the plaster surface can collects standby.
Claims (4)
1, a kind of medicine for the treatment of hyperosteogeny disease is characterized in that this medicine is that raw material is made with the Chinese herbal medicine, and its raw material percentage composition is as follows:
Radix Notoginseng 1.5-2% Rhizoma Chuanxiong 1.5-2% Radix Angelicae Dahuricae 1.5-2% Olibanum 1.5-1%
Myrrha 0.5-1% Semen Persicae 0.5-1% Rhizoma Corydalis 0.5-1% Flos Carthami 0.5-1%
Sanguis Draxonis 0.5-1% Borneolum Syntheticum 0.5-1% catechu 0.5-1% Herba Asari 0.5-1%
Cortex Cinnamomi 0.5-1% Rhizoma Et Radix Notopterygii 0.5-1% Radix Saposhnikoviae 0.5-1% Herba Schizonepetae 0.5-1%
Radix Clematidis 0.5-1% Fructus Psoraleae 0.5-1% Rhizoma Drynariae 1-1.5%
Radix Achyranthis Bidentatae 1-1.5% Radix Angelicae Sinensis 1-1.5% Radix Astragali 1-1.5%
Artificial Moschus 0.1-0.5% Oleum Sesami 50-60% Plumbum preparatium 20-30%.
2, wherein the percentage by weight of each raw material is as follows for the medicine of treatment hyperosteogeny according to claim 1:
Radix Notoginseng 1.5% Rhizoma Chuanxiong 1.5% Radix Angelicae Dahuricae 1.5% Olibanum 0.9% Myrrha 0.9%
Semen Persicae 0.9% Rhizoma Corydalis 0.9% Flos Carthami 0.9% Sanguis Draxonis 0.9% Borneolum Syntheticum 0.6%
Catechu 0.6% Herba Asari 0.6% Cortex Cinnamomi 0.9% Rhizoma Et Radix Notopterygii 0.9% Radix Saposhnikoviae 0.9%
Herba Schizonepetae 0.9% Radix Clematidis 0.9% Fructus Psoraleae 1.3% Rhizoma Drynariae 1.3%
Radix Achyranthis Bidentatae 1.3% Radix Angelicae Sinensis 1.3% Radix Astragali 1.3% artificial Moschus 0.3%
Oleum Sesami 55% Plumbum preparatium 22%.
3,, it is characterized in that said medicament is a said black plaster dosage form on the pharmaceutics according to the medicine of the described treatment hyperosteogeny of one of right 1-2.
4,, it is characterized in that preparation method of the present invention comprises the steps: according to the preparation method of right 3 described treatment hyperosteogeny medicines
(1), soaks: medicine is weighed accurately by recipe quantity, except that Borneolum Syntheticum, artificial Moschus, get Radix Notoginseng, Olibanum, Myrrha, Sanguis Draxonis, catechu and be ground into fine powder, medicines such as Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Semen Persicae, Rhizoma Corydalis, Flos Carthami, Radix Astragali, Rhizoma Drynariae, Herba Asari, Cortex Cinnamomi, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Herba Schizonepetae, Radix Clematidis, Fructus Psoraleae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis are soaked in Oleum Sesami, steeped spring 5 days, soaked summer 2 days, soaked hot day 7 days, soaked winter 10 days.
(2) the fried oil of getting it filled
It is withered and yellow that the medicine that soaked oil is heated to spice with slow fire earlier, and temperature is no more than 220 ℃, and is fried to the outside dark brown of spice, and inner coke yellow, but not carbonization, blackening be advisable removes slag from fire is cold slightly, filters and promptly gets medicine oil.
(3) oil refining
The heating of fluid after removing slag is tempered, and treats that refining can descend pellet when dripping into pearl.
(4) pilling and pasting
At this moment otherwise stop stirring the good oil of refining is added the Plumbum preparatium,, in case the heavy poly-the bottom of a pan of red powder emits to the greatest extent to white cigarette, medicine oil is taken out during for pitchy by brown stain and splashes on a small quantity in the cold water, takes out after the several seconds, and the tack-free denseness of ointment is suitable.
(5) releasing fire-toxin
After plaster was boiled into, impouring was got ready in the cold water and is constantly stirred, and should change cold water in addition when the water heating, and the back of condensing is taken out and pinched pressure repeatedly, and makes agglomerate, is dipped in the cold water, changes water every day one time, soaks 15 days winters, 5 days summers 7.
(6) mix the fines medicine
Get the plaster agglomerate and put in the container, in water-bath, dissolve, make temperature in the time of 60～70 ℃, mix into fines medicines such as Radix Notoginseng, Olibanum, Myrrha, Sanguis Draxonis, catechu, Borneolum Syntheticum, stir evenly.
(7) stand is coated with
Take by weighing the plaster of constant weight, spread out in paper or cloth etc. and mount on the backing material,, the artificial Moschus is spread on the plaster surface can collects standby.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB981105327A CN1140274C (en) | 1998-10-28 | 1998-10-28 | Gu'anning ointment for treating hyperosteogeny and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB981105327A CN1140274C (en) | 1998-10-28 | 1998-10-28 | Gu'anning ointment for treating hyperosteogeny and its prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1213554A CN1213554A (en) | 1999-04-14 |
| CN1140274C true CN1140274C (en) | 2004-03-03 |
Family
ID=5220571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB981105327A Expired - Fee Related CN1140274C (en) | 1998-10-28 | 1998-10-28 | Gu'anning ointment for treating hyperosteogeny and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1140274C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1943635B (en) * | 2006-10-27 | 2010-04-21 | 王德振 | Chinese traditional medicinal preparation for treating bone injuries and osteonosus |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001091769A2 (en) * | 2000-06-01 | 2001-12-06 | Theralife, Inc. | Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| CN102920874B (en) * | 2012-11-19 | 2014-03-12 | 刘方明 | Medicinal paste for treating infection |
| CN107412622A (en) * | 2017-08-24 | 2017-12-01 | 李永富 | A kind of ointment for rheumatic spur and its preparation method and application |
| CN109419926A (en) * | 2017-08-29 | 2019-03-05 | 河北万岁药业有限公司 | Wheeling spur treats cream and its preparation process |
| CN112603958B (en) * | 2021-01-12 | 2022-01-04 | 南方医科大学 | A kind of traditional Chinese medicine composition for treating myofasculitis, preparation method and application thereof |
-
1998
- 1998-10-28 CN CNB981105327A patent/CN1140274C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1943635B (en) * | 2006-10-27 | 2010-04-21 | 王德振 | Chinese traditional medicinal preparation for treating bone injuries and osteonosus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1213554A (en) | 1999-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101569667A (en) | Medicament for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN103006861A (en) | External-use medicine for treating neck, shoulder, waist and leg diseases and osteoproliferation, and preparation method of medicine | |
| CN101181568B (en) | Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache | |
| CN103505659A (en) | Chinese proprietary medicine for treating rheumatoid arthritis | |
| CN102008610A (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN1140274C (en) | Gu'anning ointment for treating hyperosteogeny and its prepn. method | |
| CN105687587A (en) | Ointment for warming channels and dredging collaterals as well as alleviating pain | |
| CN104306475B (en) | The medicine of a kind of mud stick treatment bone joint pain and processing method thereof | |
| CN100421687C (en) | Chinese medicine for treating kidney insufficiency | |
| CN104721313B (en) | A kind of care drug for the treatment of acute lumbar injury | |
| CN103585414B (en) | Pharmaceutical composition for treating sciatica and osteoporosis | |
| CN106540229A (en) | A kind of exterior-applied medical wine for treating cold pain disease and preparation method thereof | |
| CN1213553A (en) | Gu'anning ointment for treating hyperosteogeny and its prepn. method | |
| CN1994380B (en) | Externally applied medicine for treating arthritis, hot pack and preparation method thereof | |
| CN105853499A (en) | Ostealgia and arthritis treatment drug for external use, preparation method thereof and ointment for external use | |
| CN101181487B (en) | Chinese medicine composition orally taken for curing osteosporosis | |
| CN100496596C (en) | Improved Chinese medicinal paste for arthralgia and its preparation | |
| CN1142968A (en) | Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny | |
| CN105561270A (en) | Analgesic Chinese herbal medicine for external application and preparation method thereof | |
| CN1309406C (en) | Medicinal preparation for treating rheumatism and rheumatoid diseases | |
| CN103989968A (en) | Oral traditional Chinese medicinal composition for treating cervical spinal stenosis | |
| CN103599321A (en) | Traditional Chinese medicine composition for treating osteoporosis | |
| CN109847034A (en) | It is a kind of to treat rheumatism, rheumatoid arthritis and plaster for preventing painful swelling of joints and preparation method thereof | |
| CN102641348B (en) | Collateral-dredging and pain-relieving powder and preparation method thereof | |
| CN1171967A (en) | Medicinal liquid Yuyepizhengke for curing rheumatic arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040303 Termination date: 20101028 |